Comparative investigation between the effect of aromatherapy with Rosa damascena Mill. and Mindfulness-Based Stress Reduction (MBSR) on gestational hypertension in pregnant women

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230313057700N1

Enrollment

Registered

2023-05-13

Start date

2023-05-22

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational hypertension. Gestational [pregnancy-induced] hypertension without significant proteinuria

Interventions

Intervention 1: Intervention group: First- the group treated with Rosa damascena aromatherapy - which is treated with 40% Rosa damascena essential oil from Barich Essential Oil Company, inhaled twice

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Iranian race Age 18 to 40 Being literate Singleton pregnancy The first visit before the 16th week of pregnancy Systolic blood pressure more than 14 and diastolic blood pressure more than 9 The number of pregnancies is 4 or less Healthy sense of smell

Exclusion criteria

Exclusion criteria: History of high blood pressure before the current pregnancy or in the first 20 weeks (80/130 or more) Suffering from pre-eclampsia and eclampsia in previous pregnancies Taking psychiatric drugs Suffering from anxiety and depression Allergy to Rosa damascena essential oil or history of allergies and respiratory diseases

Design outcomes

Primary

Measure	Time frame
Systolic blood pressure. Timepoint: At the beginning of the intervention - twice a week during the intervention - immediately after the end of the intervention. Method of measurement: Mercury sphygmomanometer model ALPK2 made in Japan.;Diastolic blood pressure. Timepoint: At the beginning of the intervention - twice a week during the intervention - immediately after the end of the intervention. Method of measurement: Mercury sphygmomanometer model ALPK2 made in Japan.	—

Measure

Time frame

Systolic blood pressure. Timepoint: At the beginning of the intervention - twice a week during the intervention - immediately after the end of the intervention. Method of measurement: Mercury sphygmomanometer model ALPK2 made in Japan.;Diastolic blood pressure. Timepoint: At the beginning of the intervention - twice a week during the intervention - immediately after the end of the intervention. Method of measurement: Mercury sphygmomanometer model ALPK2 made in Japan.

—

Secondary

Measure	Time frame
Anxiety. Timepoint: Before the start of the intervention - immediately after the end of the intervention. Method of measurement: Questionnaire DASS-21.;Depression. Timepoint: Before the start of the intervention - immediately after the end of the intervention. Method of measurement: Questionnaire 21-DASS.;Stress. Timepoint: Before the start of the intervention - immediately after the end of the intervention. Method of measurement: Questionnaire 21-DASS.	—

Measure

Time frame

Anxiety. Timepoint: Before the start of the intervention - immediately after the end of the intervention. Method of measurement: Questionnaire DASS-21.;Depression. Timepoint: Before the start of the intervention - immediately after the end of the intervention. Method of measurement: Questionnaire 21-DASS.;Stress. Timepoint: Before the start of the intervention - immediately after the end of the intervention. Method of measurement: Questionnaire 21-DASS.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoume Ghazanfarpour

Kerman University of Medical Sciences

masoumeh.ghazanfarpour@yahoo.com+98 34 3231 0057

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026